Literature DB >> 1366596

Purification and characterization of immunoglobulin production stimulating factor derived from human B lymphoblastoid HO-323 cells.

K Toyoda1, T Sugahara, K Inouye, K Yamada, S Shirahata, H Murakami.   

Abstract

An immunoglobulin (Ig) production stimulating factor (IPSF) for hybridomas was found in spent medium of the human B lymphoblastoid cell line, HO-323. The IPSF was purified by serial use of DEAE chromatography, ultrafiltration, gel filtration and HPLC-DEAE chromatography. Purified IPSF was estimated to be a 410 k macro molecule by gel filtration, and contained three types of isomers which were separated from each other by native polyacrylamide gel electrophoresis. All of the isomers were, however, assumed to have the same protein components by SDS polyacrylamide gel electrophoresis. The IPSF was effective for human-human and mouse-mouse hybridomas producing IgM, but not for IgG producers in the experimental condition used here. Human-human hybridoma HF10B4, cultured in IPSF-containing medium, produced 20 times more IgM than in IPSF-free medium under serum-free conditions. The IPSF showed very little proliferation stimulating activity on HF10B4 cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1366596     DOI: 10.1007/bf00143681

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  17 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  BSF-2 is not just a differentiation factor.

Authors:  A Billiau
Journal:  Nature       Date:  1986 Dec 4-10       Impact factor: 49.962

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component.

Authors:  H Murakami; H Masui; G H Sato; N Sueoka; T P Chow; T Kano-Sueoka
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

5.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10

6.  Partial purification and characterization of immunoglobulin production stimulating factor derived from Namalwa cells.

Authors:  K Yamada; K Akiyoshi; H Murakami; T Sugahara; I Ikeda; K Toyoda; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1989-03

7.  Purification and physicochemical characterization of murine T cell replacing factor (TRF).

Authors:  K Takatsu; N Harada; Y Hara; Y Takahama; G Yamada; K Dobashi; T Hamaoka
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

8.  Identification of lactoferrin as an essential growth factor for human lymphocytic cell lines in serum-free medium.

Authors:  S Hashizume; K Kuroda; H Murakami
Journal:  Biochim Biophys Acta       Date:  1983-12-19

9.  Effect of B cell differentiation factor (BCDF) on biosynthesis and secretion of immunoglobulin molecules in human B cell lines.

Authors:  H Kikutani; T Taga; S Akira; H Kishi; Y Miki; O Saiki; Y Yamamura; T Kishimoto
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

10.  Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.

Authors:  J Van Damme; G Opdenakker; R J Simpson; M R Rubira; S Cayphas; A Vink; A Billiau; J Van Snick
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  8 in total

1.  Purification of immunoglobulin production stimulation factor II alpha derived from Namalwa cells.

Authors:  T Sugahara; S Shirahata; K Yamada; H Murakami
Journal:  Cytotechnology       Date:  1991-03       Impact factor: 2.058

2.  Purification and characterization of immunoglobulin production stimulating factor-II beta derived from Namalwa cells.

Authors:  T Sugahara; H Nakajima; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

Review 3.  Physiological enhancement of immunoglobulin production of hybridomas in serum-free media.

Authors:  H Murakami; K Yamada; S Shirahata; A Enomoto; S Kaminogawa
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

4.  Stimulation of proliferation and immunoglobulin production of human-human hybridoma by various types of caseins and their protease digests.

Authors:  K Yamada; I Ikeda; H Nakajima; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1991-03       Impact factor: 2.058

5.  Changes in monoclonal antibody productivity of recombinant BHK cells immobilized in collagen gel particles.

Authors:  M Yamaguchi; Y Shirai; Y Inouye; M Shoji; M Kamei; S Hashizume; S Shirahata
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

6.  Lysozyme stimulates immunoglobulin production by human-human hybridoma and human peripheral blood lymphocytes.

Authors:  F Murakami; T Sasaki; T Sugahara
Journal:  Cytotechnology       Date:  1997-07       Impact factor: 2.058

7.  Immunoglobulin production stimulating factor-II alpha (IPSF-II alpha) is glyceraldehyde-3-phosphate dehydrogenase like protein.

Authors:  T Sugahara; S Shirahata; K Akiyoshi; T Isobe; T Okuyama; H Murakami
Journal:  Cytotechnology       Date:  1991-06       Impact factor: 2.058

8.  Enhanced CEA production associated with aspirin in a culture of CW-2 cells on some polymeric films.

Authors:  A Higuchi; S Uchiyama; M Demura; T Asakura; C S Cho; T Akaike; H Takarada; M Hara
Journal:  Cytotechnology       Date:  1999-11       Impact factor: 2.058

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.